Genome-wide miRNA, gene and methylation analysis of triple negative breast cancer to identify changes associated with lymph node metastases
Triple negative breast cancer (TNBC) is a particularly important breast cancer subtype with an aggressive clinical phenotype that is associated with a higher likelihood of metastasis. This subtype is characterized by an absence of the estrogen (ER) and progesterone (PR) receptors, as well as the hum...
Main Authors: | Kelly A. Avery-Kiejda, Andrea Mathe, Rodney J. Scott |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-12-01
|
Series: | Genomics Data |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213596017301046 |
Similar Items
-
miRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer
by: Andrea Mathe, et al.
Published: (2015-11-01) -
Copy number variation in triple negative breast cancer samples associated with lymph node metastasis
by: Mamta Pariyar, et al.
Published: (2021-08-01) -
Validation of expression patterns for nine miRNAs in 204 lymph-node negative breast cancers.
by: Kristin Jonsdottir, et al.
Published: (2012-01-01) -
Methylation signature of lymph node metastases in breast cancer patients
by: Barekati Zeinab, et al.
Published: (2012-06-01) -
Heterogeneity of PD-L1 expression in primary tumors and paired lymph node metastases of triple negative breast cancer
by: Ming Li, et al.
Published: (2018-01-01)